|
English
|
正體中文
|
简体中文
|
總筆數 :0
|
|
造訪人次 :
53256554
線上人數 :
814
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
"leu w j"的相關文件
顯示項目 36-44 / 44 (共5頁)
<< < 1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-06-02T05:43:17Z |
Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling
|
Hsu J.-L.;Leu W.-J.;Hsu L.-C.;Ho C.-H.;Liu S.-P.;Jih-Hwa Guh; Hsu J.-L.; Leu W.-J.; Hsu L.-C.; Ho C.-H.; Liu S.-P.; JIH-HWA GUH |
| 臺大學術典藏 |
2021-06-02T05:43:13Z |
Chalcones Display Anti-NLRP3 Inflammasome Activity in Macrophages through Inhibition of Both Priming and Activation Steps-Structure-Activity-Relationship and Mechanism Studies
|
Leu W.-J.;Chu J.-C.;Hsu J.-L.;Du C.-M.;Jiang Y.-H.;Hsu L.-C.;Huang W.-J.;Jih-Hwa Guh; Leu W.-J.; Chu J.-C.; Hsu J.-L.; Du C.-M.; Jiang Y.-H.; Hsu L.-C.; Huang W.-J.; JIH-HWA GUH |
| 臺大學術典藏 |
2021-01-29T03:17:17Z |
Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: The role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways
|
Leu W.-J.; Swain S.P.; Chan S.-H.; Hsu J.-L.; SHIH-PING LIU; Chan M.-L.; Yu C.-C.; Hsu L.-C.; Chou Y.-L.; Chang W.-L.; Hou D.-R.; Guh J.-H. |
| 臺大學術典藏 |
2021-01-29T03:17:15Z |
Enantiomerically pure β-dipeptide derivative induces anticancer activity against human hormone-refractory prostate cancer through both PI3K/Akt-dependent and -independent pathways
|
Chan M.-L.;Yu C.-C.;Hsu J.-L.;Leu W.-J.;Chan S.-H.;Hsu L.-C.;Shih-Ping Liu;Ivantcova P.M.;Dogan ?.;Br?Se S.;Kudryavtsev K.V.;Guh J.-H.; Chan M.-L.; Yu C.-C.; Hsu J.-L.; Leu W.-J.; Chan S.-H.; Hsu L.-C.; SHIH-PING LIU; Ivantcova P.M.; Dogan ?.; Br?se S.; Kudryavtsev K.V.; Guh J.-H. |
| 臺大學術典藏 |
2021-01-29T03:17:14Z |
Para-toluenesulfonamide induces anti-tumor activity through Akt-dependent and -independent mTOR/p70S6K pathway: Roles of lipid raft and cholesterol contents
|
Hsu J.-L.;Leu W.-J.;Hsu L.-C.;Shih-Ping Liu;Zhong N.-S.;Guh J.-H.; Hsu J.-L.; Leu W.-J.; Hsu L.-C.; SHIH-PING LIU; Zhong N.-S.; Guh J.-H. |
| 臺大學術典藏 |
2021-01-29T03:17:13Z |
Phosphodiesterase type 5 (PDE5) inhibitors sensitize topoisomerase II inhibitors in killing prostate cancer through PDE5-independent impairment of HR and NHEJ DNA repair systems
|
Chang J.-F.;Hsu J.-L.;Sheng Y.-H.;Leu W.-J.;Yu C.-C.;Chan S.-H.;Chan M.-L.;Hsu L.-C.;Shih-Ping Liu;Guh J.-H.; Chang J.-F.; Hsu J.-L.; Sheng Y.-H.; Leu W.-J.; Yu C.-C.; Chan S.-H.; Chan M.-L.; Hsu L.-C.; SHIH-PING LIU; Guh J.-H. |
| 臺大學術典藏 |
2021-01-29T03:17:11Z |
Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling
|
Hsu J.-L.; Leu W.-J.; Hsu L.-C.; Ho C.-H.; SHIH-PING LIU; Guh J.-H. |
| 臺大學術典藏 |
2018-09-10T15:26:46Z |
Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer - A crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation
|
Chang, W.-L.;Hsu, L.-C.;Leu, W.-J.;Chen, C.-S.;Guh, J.-H.; JIH-HWA GUH |
| 臺大學術典藏 |
2018-09-10T15:26:45Z |
Catalytic transfer hydrogenation and anticancer activity of arene-ruthenium compounds incorporating bi-dentate precursors
|
Chang, Y.-H.;Leu, W.-J.;Datta, A.;Hsiao, H.-C.;Lin, C.-H.;Guh, J.-H.;Huang, J.-H.; JIH-HWA GUH |
顯示項目 36-44 / 44 (共5頁)
<< < 1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
|
